T0	Participants 98 147	postmenopausal women with advanced breast cancer.
T1	Participants 149 270	Eighty-eight postmenopausal women with metastatic breast cancer, in whom estrogen receptors (ER) were positive or unknown
T2	Participants 512 568	Patients with known ER negative status were not studied.
T3	Participants 1172 1224	postmenopausal patients with advanced breast cancer.